For example, genomic profiling of ALL has demonstrated recurring abnormalities in the CRLF2 gene resulting in overexpression of the encoded protein TSLPR in approximately 5–10% of B ALL. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.